Blueberries Medical Company (ID) (BBRRF)

Yeah I was stoked I was able to load up at .011 so got my average down to .0201… We should be ending the year strongly. There’s a little more info in StockTwits channel since it’s kinda hard finding intel on Blueberries. Another avenue is via Instagram following Garreton (CEO)

Yes I am still an investor. Holding a bag at a significant paper loss but this was always a long term investment for me. Encouraged by your update / their current status and think anyone new to Blueberries considering buying at this crazy low share price is very fortunate indeed.

Are you still in Blueberries? They seem to be developing nicely cutting expenses and shifting from cultivation to extraction. Sales to Australia already happening and soon Brazil and Peru too, not to mention a JV with Allied for sales in Switzerland (GMP certified partner

I see no one has posted here in a whole year… have you still been following Blueberries and what Garreton has been doing?

Won’t this new Colombian law benefit Blueberries? I’m hearing only Khiron has most of not all the Colombian medical sales atm

CEO & CFO Purchased more shares in open market again this past week (CEO 11/19/21 88,000 shares); (CFO 11/22-11/24 over 200,000 shares). Somewhat encouraging.

$174,000 in revenues with $1,900,000 in expenses after all this time?

With export restrictions eased, Colombia's medical cannabis business is poised for liftoff:

https://www.cnn.com/2021/10/24/business/legal-cannabis-colombia-export/index.html

Absolute bargain PPS here given what is around the corner..

Blueberries SAS at Bogota, Colombia has made one of the biggest exports of Premium CBD Full Spectrum Oil of all time, scaling up its business to a level that will improve life condition of more than 2.500 patients in Peru
https://finance.yahoo.com/news/blueberries-medical-announces-wholly-subsidiary-113000785.html

Blueberries' CFO is buying shares again - always a very good sign. Exciting times ahead.

Watch this. Better still, invest in Blueberries and Khiron given the Mexico legalization news.

Blueberries' leaders keep buying which is very telling / encouraging.

Sea of red across the market today. Blueberries' next revenue report (May) anticipated to be strong which should raise the share price once again. As they are just getting started actually selling and with Mexico legalizing etc. the future does appear very promising indeed. As such I am adding 125k shares here. Bargain for a top tier LATAM based MJ company in this day and age.

Heading back up with strength. +10% today. Still a great entry / adding point here given what is unfolding.

Still dropping lower and lower

Wow. Buying all I can at this insanely low PPS. One word > Mexico.

It is the MJ sector vs anything Blueberries related. Shall pass and rise again.

What the heck happened here today? Can’t find anything to justify a 14% drop on high volume... no news :-S

NEWS: Blueberries Medical Signs Framework Agreement with YVY Life Sciences of Uruguay.

Toronto, Ontario (March 26, 2021) – Blueberries Medical Corp. (CSE: BBM) (OTC: BBRRF) (FRA: 1OA) the Canadian parent of Blueberries S.A.S., the premier Latin American licensed cultivator and producer of medicinal cannabis and medicinal-grade cannabis extracts, (together the “Company” or "Blueberries"),today announced that it has signed a Framework Agreement with Mechelen S.A., a subsidiary of YVY Life Sciences (“YVY”) for mutual development of strains and genetics in Colombia and potentially exporting dry cannabis flower of mutual strains from Uruguay.This is Blueberries’ first agreement in Uruguay and the next step in Blueberries’ international growth strategy under way. In December 2013, Uruguay, became the first country in the world to legalize recreational cannabis, starting a ripple effect throughout the world and particularly in Latin America, which continues to this day. With this agreement, Blueberries will expand its reach to a new jurisdiction, and through the Mercosur Regional Free Trade Bloc, will gain access to Brazil. Latin America, which includes Colombia, Argentina, Peru and Uruguay, is a highly populous potential market, with countries that have recent or pending legislation permitting access to cannabis and CBD oils for medicinal use. YVY is dedicated to the production of dried flowers of medicinal cannabis with their focus on sustainable and high-quality cannabis and hemp cultivation, harvesting their first sustainable crops in April 2020. “We are incredibly pleased with the concept of co-developing new cannabis genetics in collaboration with YVY, and with the opportunity to replicate their unique cultivation model that will bring multiple benefits to our operations in Colombia.” said Jose Forero, Blueberries President of Latin American Operations, “Likewise, we are excited with the opportunity to register our top genetics in other countries. Uruguay is the perfect jurisdiction to start our expansion into new geographies and potentially export dry flower, something that is not yet allowed in Colombia.” The Framework Agreement, dated March 24, 2021, has an initial term of five years, with customary renewal clauses and no consideration paid by neither party. It is intended as the first step in the relationship with specific accessory agreements to follow in the coming months. Under the Framework Agreement, Blueberries and YVY will structure collaborative plans, initially starting with mutual development of strains and genetics in Colombia, and consequently registration of those cultivars both in Colombia and Uruguay. This will provide a fast-track opportunity to register Blueberries’ proprietary genetics in Uruguay, thus allowing the partners to cultivate and export dry flower of Blueberries’ strains from Uruguay. “We are thrilled with this strategic alliance with Blueberries as we venture beyond Uruguay. Our goal is to work closely with Blueberries to replicate YVY’s unique cultivation model with small producers in Colombia, producing high-quality and natural products while generating scalable social and environmental impact,” said Andrea Krell, Chief Executive Officer of YVY. “Our vision is to use the Framework Agreement as the first step in a long-term strategic partnership which
will help us quickly take practical steps in developing collaborative projects both in Colombia and Uruguay.” About YVY Life Sciences YVY is a cannabis lifestyle brand comprising of natural and high-quality products, powered by an innovative and unique cultivation model. YVY operations are currently in Uruguay with expansion plans underway in Colombia and Argentina with potential distribution in Latin America and Europe. YVY’s focus and expertise is the cultivation of high-quality cannabis flower, biomass and seeds incorporating genetics R&D and strict quality control. YVY works with strategic partners to manufacture, formulate, and distribute YVY branded products targeting the wellness segment. For more information about the YVY visit www.yvylifesciences.com, or please contact: Andrea K Krell, Chief Executive Officer andrea@yvylifesciences.comTel: +598 92 151 456 About Blueberries Medical Corp. Blueberries is a Latin American licensed producer of naturally grown premium quality cannabis with its primary operations ideally located in the Bogotá Savannah of central Colombia. The Company is led by a specialized team with proprietary expertise in agriculture, genetics, extraction, medicine, pharmacology and marketing, Blueberries is fully licensed for the cultivation, production, domestic distribution, and international export of CBD and THC-based medical cannabis in Colombia. Blueberries’ combination of leading scientific expertise, agricultural advantages and distribution arrangements has positioned the Company to become a leading international supplier of naturally grown, processed, and standardized medicinal-grade cannabis oil extracts and related products. Additional information about the Company is available at www.blueberriesmed.com.

Spring Sale price right here folks. Bargain price for a future LATAM leader and global exporter.

Top of the morning to ya. Mostly red but we are green of course. Onward and upward!

So undervalued against it's future and so under the radar this one. More cheap shares for me I guess!
Wealth ahoy!

Blueberries Medical Enters Growing Peruvian Medical Cannabis Market: Enters Binding LOI with Futura Farms Toronto, Ontario (March 15, 2021)

Blueberries Medical Corp. (CSE: BBM) (OTC: BBRRF) (FRA: 1OA) (the “Company” or "Blueberries"),a Latin American licensed producer of medicinal cannabis and cannabis-derived products, today announced its wholly owned subsidiary Blueberries SAS will supply premium, formulated cannabis oil to Futura Farms, a licensed distributor serving the Peruvian market.This is the Company ´s first agreement in Peru and the next step in Blueberries’ international growth strategy under way. As part of this strategy, the Company has initiated distribution of its medical and wellness products to Colombia, USA and now Peru. With a population of 33 million, and the fifth largest economy in Latin America, Peru’s medical cannabis market is estimated to be worth US$99 million (Prohibition Partners). With a regulatory environment similar to Colombia, Peru is an early mover in Latin America, and has established a legal framework for producing, importing, and selling cannabis products for medical use. Consequently, the Peruvian market is advancing rapidly and has the potential to register diverse cannabis-based products. Futura Farms is a pioneer company in the development of the medical cannabis sector in Peru and Latin America, creating alliances with key partners in the industry worldwide, utilizing its expertise in the field, and reaffirming its commitment to improve the quality of life in the region. “As we undertake our global strategy, it is essential for us to partner with companies such as Futura Farms that not only have the expertise in their local markets, but also have an authentic appreciation for the patients’ needs and a constant commitment to scientific developments. We have great expectations about this initiative,” said Jose Forero, Blueberries President of Latin American Operations. “Peru is one of the top medical cannabis markets in the Latin America and Futura Farms is one of very few companies with a cannabis importation license in that country, making this agreement of outstanding strategic value to Blueberries’ international expansion.” The agreement consists of initially supplying 200 kg of bulk, premium, formulated cannabis oil to be delivered to Peru in 2021, to be marketed to the licensed pharmaceutical establishments that have fulfilled their Good Storage Practices (“GSP”) requirements issued by Peru's General Directorate of Medicines, Supplies and Drugs (“DIGEMID”). “Blueberries is an outstanding ally that will allow us to bring certified high-quality products to our market. I have personally seen the passion they put into their cultivation, extraction, and production processes, which will easily translate into successful cannabis-based treatments. We feel confident that this strategic partnership will help propel the medicinal cannabis industry in Peru,” said Jose Escalante, Chief Executive Officer of Futura Farms. “Our vision is to democratize the use of medical cannabis and we are thrilled to have found a company like Blueberries, whose values resonate with our own.”
About Futura Farms Futura Farms is a licensed distributor of cannabis-based products, with operations based in Lima, Peru. Futura Farms is led by a team of seasoned professionals with expertise in medicine, education, marketing, and product and business development in the pharmaceutical industry. With a clear vision to democratize the access to medical cannabis, they have specialized in the development of products and services that enhance the physician and patient experience within cannabis-based treatments. Futura Farms is fully licensed for the distribution of CBD and THC derived products in Peru. For more information about the Company visit www.futurafarms.pe, or please contact: Jose Escalante, Chief Executive Officer jose@futurafarms.peTel: +51 923 270 879 Raul Injoque, Chief Operating Officer raul@futurafarms.peTel: +51 943 223 934 About Blueberries Medical Corp. Blueberries is a Latin American licensed producer of naturally grown premium quality cannabis with its primary operations ideally located in the Bogotá Savannah of central Colombia. The Company is led by a specialized team with proprietary expertise in agriculture, genetics, extraction, medicine, pharmacology and marketing, Blueberries is fully licensed for the cultivation, production, domestic distribution, and international export of CBD and THC-based medical cannabis in Colombia. Blueberries’ combination of leading scientific expertise, agricultural advantages and distribution arrangements has positioned the Company to become a leading international supplier of naturally grown, processed, and standardized medicinal-grade cannabis oil extracts and related products.

Additional information about the Company is available at www.blueberriesmed.com. For more information, please contact: Jose Forero, President, Latin American Operations jforero@blueberriesmed.comTel: +57 310 345 8808 Ian Atacan, Chief Financial Officer iatacan@blueberriesmed.comTel: +1 (416) 562 3220 Cautionary Note Regarding Forward-Looking Information

With Mexico legalizing and other countries to follow suit (e.g. the U.S. plus other LATAM countries now that legalization and it's benefits are catching on), Blueberries is a serious BARGAIN investment at this price and anything under a dollar frankly.

Market Cap = $21M
Outstanding shares = 142M (only!!)

I am loaded, holding and adding more as funds become available.

I know, no luck just a little waiting game now.

Your PPS is seriously excellent. GL (not that we will need actual ‘luck’ per se).

Agreed! Been buying this from .04-.14 and added more shares yesterday. GL

Mexico on the verge of full legalization then BOOM.

Adding significantly here given the near term explosions anticipated in the LATAM region (e.g. Mexico legalization). Plus if the US does legalize at the Federal level as anticipated, Europe will likely follow and this is when PRICE of Cannabis oils/extracts enters the (global) room. Blueberries is set up perfectly for this eventuality and as such I and others I am networked with are investing big time. Do your DD and GL.

Would love to see this break .20

This has weathered the red week the MJ space has experienced this week well. BUY THE DIPS HERE FOLKS, THIS WILL FLY SOON ENOUGH (do your DD).

Buying the dip as it may be the last chance saloon here. LATAM will explode soon enough and there are only a fistful of credible players on the ground. BOOM TIME in 2021+

Yes indeed! Beautiful day for sure...

Yet another beautiful day heading North! This company is so under the radar. Lucky me having built a large position which I anticipate will reward me massively. I hope others can also benefit.

BUY BIG, ADD & HOLD. LATAM Cannabis companies haven't yet had their boom run like the US & Canada but boy is it coming. MARK MY WORDS.

Beautiful move North. As a Top 5 MJ leader in LATAM, I would think that investors are finally catching on that Blueberries has a huge future ahead with Mexico legalizing etc. These few MJ companies in LATAM are the equivalent of our leading US & CAN MJ companies and look at the boom they are enjoying now!
This PPS is a BARGAIN. Pure and simple.

Just waiting for that new 52 week high...so close!

Another strong Green Day amidst a sea of red across the market. Buy and hold. Patience pays.

I must have read something wrong or maybe what I read was incorrect. I read the offering was at .065 CAD. Any idea what that is in USD? Guess I have some more research to do. Still holding and not selling for 10 cent lunch $. Go Blueberries and good luck to all.

Yet another green day. News (encouraging deal PPS of CAD $0.65):

BlueberriesMedicalCloses$1MStrategicFinancingLedbyaLeadingLatinAmericanPrivateEquityGroupwithExtensiveInternationalCannabisIndustryExpertise;AppointsFacundoGarretónasChairman&InterimCEOToronto,Ontario(January20,2021)–BlueberriesMedicalCorp.(CSE:BBM)(OTC:BBRRF)(FRA:1OA)(the“Company”or"Blueberries"),aLatinAmericanlicensedproducerofmedicinalcannabisandcannabis-derivedproducts,ispleasedtoannouncethecompletionofanon-brokeredprivateplacementforaggregategrossproceedsofC$1,000,000(the“Offering”)fromthesaleofcommonshares(“CommonShares”)at a price of C$0.065 per Common Share.TheOfferingwasledbyFLAVenturesLtd.(“FLAVentures”),aprivateequityfundbasedinBuenosAires,Argentina,whichfocusesoninvestmentsinestablishedandgrowth-orientedLatinAmericanbusinessesacrossarangeofsectors,seekingtocreateandaddstrategicvalue,drivingtheireconomicgrowthandenhancingtheirperformances.BlueberriesispleasedtowelcomeFLAVenturesasanewstrategicpartner.FLAVenturesfinancialbackers,directorsandteammembershaveavastexperienceleadingcompaniesinvolvedinthehealthcare,media,andrealestateindustriesinternationallyaswellasextensivecannabisexpertiseandstrategicinvestmentsinthecannabissectorglobally.Amongstotherstrategicbusinessinvolvements,shareholdersofFLAVenturesownGrupoAmérica,oneofthelargestmediagroupsinArgentina,andhaveextensiveadditionalstrategicrelationshipsthroughtheirdirectinvolvementinthehealthcareindustryasownersofoneofthelargestnetworksofmedicalcentersandothermedicalservicebusinessesinArgentinaandelsewhereinLatinAmerica.InconnectionwiththecompletionoftheOffering,FacundoGarretónhasbeennamedChairmanandInterimChiefExecutiveOfficeroftheCompany,andSebastianHochbaumhasbeenappointedtotheboardofdirectorsoftheCompany(the“Board”).“BlueberrieshasbuiltanimpressivecompanyinColombiaanditssophisticatedextractioncapabilitieswillplayanintegralrolewithinourglobalcannabisplatform.IamconfidentthattheinvolvementofFLAVenturesanditsstakeholderswillprovideBlueberrieswiththeopportunitytoaccelerateitsgrowthandtakeadvantageoftherapidlyexpandingcannabismarketsinLatinAmericaandaroundtheworld,”statedSebastianHochbaum“ThisstrategicinvestmentisatremendousaccomplishmentforBlueberriesandpositionsthecompanyforcommercialsuccess.TheFLAVenturesteamiscomprisedofsomeofthemostsuccessfulandhighlyrespectedentrepreneursandinvestorsinLatinAmericawhoalsohaveextensiveinvolvementandexpertiseinthecannabisindustry,”statedFacundoGarretón,ChairmanandInterimChiefExecutiveOfficer.“IamalsolookingforwardtoleadingBlueberriesaswestrivetoexecuteonadomesticandinternationalbusinessplan.”

100% BUY on Barchart.com

Some very encouraging posts from leadership on LinkedIn etc. This stock will fly soon enough and represents a great opportunity for investors vs day traders. Do your DD. GL.

https://t.co/TjgYdfFgVY#CBDnews #wellness #medicalcannabis #cannabis #cannabisindustry #medical pic.twitter.com/NQjnVeDnJD— BlueberriesMed (@BlueberriesMed) January 20, 2021

After 21 months of holding this it's nice to finally be up 70% instead of down 70. Was tempted to sell last week at .12 with a 100 % gain but can't help but think it'll go up. Hope I'm right and good luck to all holding.

Another strong green day. Mexico is about to legalize folks. Just sayin'...

Yes indeed, new$ coming.

Twitter update from Blueberry today:

“We are currently working on some very exciting projects. We will have a corporate update in the coming days. Take care!”

News Coming??????

This company is flying so under the radar. Huge future for Blueberries if you do your DD. Buying more regularly as funds become available.

Big Green days everyday of late, as anticipated. This silly low price is still a huge bargain given how dominant LATAM will be in the global cannabis space moving forward. So few players there to date and Blueberries is in the top 3 (Khiron is the dominant leader).